Lifshitz & Miller Law Firm Announces Investigation of Advaxis, Inc., Banc of California, Inc., Biogen Inc., Franklin Resources, Inc., Juniper Pharmaceuticals, Inc., Opus Bank, Taro Pharmaceutical

Biogen Inc. (BIIB)

Lifshitz & Miller announces investigation on behalf of BIIB investors. The investigation concerns whether BIIB adequately disclosed the safety risks and growth prospects of Tecfidera.

If you are a BIIB investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Franklin Resources, Inc. (BEN)

Lifshitz & Miller announces investigation on behalf of Franklin investors.  The investigation concerns whether Franklin's officers and directors breached their fiduciary duties resulting in losses for investors in excess of $64 million.

If you are a Franklin investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Juniper Pharmaceuticals, Inc. (JNP)

Lifshitz & Miller announces investigation on behalf of JNP investors.  Specifically, on October 24, 2016, JNP announced it would restate its financial statements since 2013.

If you are a JNP investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Opus Bank (OPB)

Lifshitz & Miller announces investigation on behalf of OPB investors. Specifically, whether OPB lacked adequate internal controls over accounting and financial reporting.

For additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Taro Pharmaceutical Industries Ltd. (TARO)

Lifshitz & Miller announces investigation on behalf of TARO investors. The investigation concerns whether TARO adequately disclosed potential violations of federal antitrust laws by colluding with other pharmaceutical companies.

If you are a TARO investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Tyson Foods, Inc. (TSN)

Lifshitz & Miller announces investigation on behalf of Tyson investors.  The investigation concerns whether Tyson adequately disclosed that it was involved in a potential price fixing scheme in violation of antitrust laws.

For more information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING. © 2016 Lifshitz & Miller.  The law firm responsible for this advertisement is Lifshitz & Miller, 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:
Joshua M. Lifshitz, Esq.
Lifshitz & Miller
Phone:  516-493-9780 
Facsimile: 516-280-7376
Email: info@jlclasslaw.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lifshitz--miller-law-firm-announces-investigation-of-advaxis-inc-banc-of-california-inc-biogen-inc-franklin-resources-inc-juniper-pharmaceuticals-inc-opus-bank-taro-pharmaceutical-industries-ltd-and-tyson-foods--300353518.html

SOURCE Lifshitz & Miller Law Firm